Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

40
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
40
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

20
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
20
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

38
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
38
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

16.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
16.9K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

2.0K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

41
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
41

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning analysis of breast cancer histology predicts ATM pathogenic variant carrier status.

NPJ digital medicine·2026
Same author

Correction: A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217).

BMC cancer·2026
Same author

Neuroendocrine tumours through an epigenetic lens: Emerging insights for diagnosis and treatment.

Journal of neuroendocrinology·2026
Same author

Broadening the View: Substance P and Its Metabolism in Pruritus-Related Diseases.

The Journal of dermatology·2026
Same author

[<sup>177</sup>Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial.

The Lancet. Oncology·2026
Same author

Large Language Models for Patient Education: Insights from Cross-Lingual Expert Evaluation in Radioligand Therapy for Neuroendocrine Tumors.

Journal of cancer education : the official journal of the American Association for Cancer Education·2026
Same journal

SpaceExpander: An Automated System for Drafting Markush Claims to Expand Chemical Space.

Molecular informatics·2026
Same journal

A Structure-Informed Atlas of Venom-Derived Peptides Reveals the Organization of Chemical Space.

Molecular informatics·2026
Same journal

ConGen: Targeted Molecule Generation Through Contrastive Learning and Latent Optimization.

Molecular informatics·2026
Same journal

Novel Molecules Generation Using Graph Generative Adversarial Networks.

Molecular informatics·2026
Same journal

An Attention-Driven Graph Transformer With Nonlinear Modeling and Neuro-Fuzzy Fusion for High-Order Toxic Molecular Graph Learning.

Molecular informatics·2026
Same journal

Molecular Modeling and Chemoinformatics in Ukraine.

Molecular informatics·2026
See all related articles

Related Experiment Video

Updated: Feb 22, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

13.2K

Kernel Multitask Regression for Toxicogenetics.

Elsa Bernard1, Yunlong Jiao2,3,4, Erwan Scornet5

  • 1Memorial Sloan Kettering Cancer Center, New York, USA.

Molecular Informatics
|September 27, 2017
PubMed
Summary
This summary is machine-generated.

This study introduces a machine learning approach, kernel multitask regression (KMR), to predict chemical compound toxicity using cell line genetics. The method accurately forecasts toxicity, advancing predictive toxicogenetics for personalized risk assessment.

Keywords:
Toxicogeneticskernel methodsmachine learningmultitask regression

More Related Videos

The Lambda Select cII Mutation Detection System
07:08

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

8.4K
A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

7.7K

Related Experiment Videos

Last Updated: Feb 22, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

13.2K
The Lambda Select cII Mutation Detection System
07:08

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

8.4K
A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

7.7K

Area of Science:

  • Computational toxicology
  • Genomics and transcriptomics
  • Machine learning in drug discovery

Background:

  • High-throughput in vitro assays enable quantitative toxicity studies on human cell lines.
  • Predictive toxicogenetics aims to forecast chemical toxicity for individuals based on their genetic makeup.
  • Integrating molecular, genetic, and transcriptomic data is crucial for accurate toxicity prediction.

Purpose of the Study:

  • To develop and present a machine learning-based approach for predictive toxicogenetics.
  • To combine chemical, genetic, and transcriptomic data for toxicity prediction.
  • To evaluate the proposed method's performance in a real-world toxicogenetics challenge.

Main Methods:

  • Kernel multitask regression (KMR) was employed as the machine learning model.
  • Chemical descriptors were used to characterize molecular compounds.
  • Genetic and transcriptomic data characterized the human-derived cell lines.

Main Results:

  • The kernel multitask regression (KMR) approach demonstrated strong predictive performance.
  • The method ranked among the top models in the DREAM8 Toxicogenetics challenge.
  • The study highlighted the significance of selecting appropriate descriptors for chemicals and cell lines.

Conclusions:

  • The developed machine learning approach offers a powerful tool for predictive toxicogenetics.
  • Accurate prediction of chemical toxicity can be achieved by integrating diverse data sources.
  • Further research should focus on optimizing feature selection for enhanced predictive accuracy.